Viewing Study NCT02564133


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-02-01 @ 1:59 PM
Study NCT ID: NCT02564133
Status: TERMINATED
Last Update Posted: 2017-08-09
First Post: 2015-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Hip Fracture and Patent Foramen Ovale
Sponsor: Hopital Foch
Organization:

Study Overview

Official Title: Are Postoperative Complications More Frequent When Patients Having a Hip Fracture Have a Patent Foramen Ovale ?
Status: TERMINATED
Status Verified Date: 2017-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: We have discovered a too low prevalence of Patent Foramen Ovale compared to the theoretical % of around 20-25%.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: COL-FOP
Brief Summary: Ereth et al. showed in 1992, using transesophageal echocardiography, that the implantation of a hip prosthesis may be complicated by intracardiac embolization of various origin.

A patent foramen ovale exists in approximately one fifth of the population; it facilitates the passage of embolus from the right heart to the left one and then especially to the coronary vessels and to the brain.

The hypothesis supported in this research is that the prevalence of postoperative complications, especially neurological ones, is increased after surgery for hip fracture when patients have a patent foramen ovale.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2012-A01155-38 OTHER ANSM View